ATLAS / Macro Radar / Reporting / LTRN

Lantern Pharma Inc. (LTRN) reporting calendar

Lantern Pharma Inc. files periodic reports with the SEC as LTRN on Nasdaq. Atlas tracks 24 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
19 Jul 2026 – 7 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
24

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001493152-26-023740
10-K31 Dec 202530 Mar 202689 days0001493152-26-013612
10-Q30 Sep 202512 Nov 202543 days0001493152-25-021927
10-Q30 Jun 202513 Aug 202544 days0001641172-25-023471
10-Q31 Mar 202515 May 202545 days0001641172-25-010547
10-K31 Dec 202427 Mar 202586 days0001641172-25-000926
10-Q30 Sep 20247 Nov 202438 days0001493152-24-044010
10-Q30 Jun 20248 Aug 202439 days0001493152-24-030766
10-Q31 Mar 20249 May 202439 days0001493152-24-018422
10-K31 Dec 202318 Mar 202478 days0001493152-24-010302
10-Q30 Sep 20238 Nov 202339 days0001493152-23-039896
10-Q30 Jun 20239 Aug 202340 days0001493152-23-027345
10-Q31 Mar 20239 May 202339 days0001493152-23-015940
10-K31 Dec 202220 Mar 202379 days0001493152-23-008241
10-Q30 Sep 20227 Nov 202238 days0001493152-22-030819
10-Q30 Jun 20228 Aug 202239 days0001493152-22-021610
10-Q31 Mar 20223 May 202233 days0001213900-22-023583
10-K31 Dec 202110 Mar 202269 days0001213900-22-011581
10-Q30 Sep 20211 Nov 202132 days0001213900-21-055780
10-Q30 Jun 202129 Jul 202129 days0001213900-21-039286
10-Q31 Mar 20213 May 202133 days0001213900-21-024222
10-K31 Dec 202010 Mar 202169 days0001213900-21-014576
10-Q30 Sep 202029 Oct 202029 days0001213900-20-033954
10-Q30 Jun 202030 Jul 202030 days0001213900-20-019151

Source: SEC EDGAR company submissions for CIK 0001763950. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.